Olink Holding AB Sponsored ADR OLK 深 滬
交易中 09-09 12:00:38 美东时间
26.08
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 26.08
- 總市值 32.34亿
- 52周最高 26.09
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 14.10
- 委 比 0.00%
- 總股本 1.24亿
- 歷史最高 42.20
- 量 比 0
- 振 幅 0.00%
- 歷史最低 8.39
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oxford Lane Capital Corp. Announces Further Detail on its Previously Announced 1-for-5 Reverse Stock Split
Oxford Lane Capital Corp. announced it will implement a 1-for-5 reverse stock split effective September 5, 2025, with trading adjusting on September 8. Each 5 shares will become 1, without changing par value. Monthly distributions will increase from $0.09 to $0.45 (September) and $0.08 to $0.40 (October-December). No fractional shares will be issued; cash payments will replace them. Shareholders holding certificates will receive instructions from...
09-02 12:00
AI Power Crunch Looms: Can Oklo's Nuclear Reactors Save Data Centers?
Oklo Inc. (NYSE: OKLO) offers scalable nuclear reactors to address data center power shortage. Analysts rate it a Buy with $92 target.
08-27 00:03
Oxford Lane Capital Corp. Provides Update on Share Repurchase Program
Oxford Lane Capital Corp. has repurchased approximately 4.9 million shares of its common stock for $17.4 million, with an average price of $3.53 per share, from July 24 to August 13, 2025. This leaves approximately $132.7 million available under its $150 million Share Repurchase Program, which is expected to continue until March 20, 2026. The company will determine the timing, manner, and amount of future repurchases based on market conditions an...
08-14 12:00
最高工资1.64亿美元！盘点医疗器械企业十大最强“打工人”
（来源：医趋势） 近日，Fierce Fharma对2024年十大薪酬最高的医疗器械公司 CEO进行了统计，所计算的薪酬总额包括工资、股票与期权奖...
07-30 11:45
因美纳将收购SomaLogic，加速蛋白质组学业务并推进公司多组学战略
将高度互补的蛋白质组学技术专长与因美纳行业领先的产品创新和全球市场影响力相结合 为因美纳在广阔且持续增长的市场中实现增长奠定基础 自2021年末以来，因美纳与...
06-23 22:21
Oxford Lane Capital Corp. Provides May 2025 Net Asset Value Update
Oxford Lane Capital Corp. announced an unaudited estimate of its net asset value (NAV) per share of common stock as of May 31, 2025, ranging between $4.17 and $4.27. The company noted that this estimate is not a comprehensive financial statement and may differ from the actual NAV as of June 30, 2025. As of May 31, 2025, approximately 481.6 million shares of common stock were issued and outstanding. The fair value of the company's portfolio invest...
06-10 12:00
诺禾致源获Olink CSP认证，加速全球蛋白质组学服务本地化
2025年6月3日，诺禾致源与 Olink Proteomics 共同为“诺禾致源 Olink CSP (Certified Service Provider...
06-05 17:06
淳厚基金近期调研华大智造，旗下淳厚信泽A(007811)近五年收益排名同类混合型基金前5%
根据披露的机构调研信息2025年3月1日至2025年3月12日，淳厚基金对上市公司华大智造进行了调研。基金市场数据显示，淳厚基金成立于2018年11月3日。截至...
03-14 14:57
Ultima Genomics Announces Linda Ramirez as Chief Legal Officer
FREMONT, Calif., March 11, 2025 /PRNewswire/ -- Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that Linda Ramirez will join ...
03-11 23:00
